December 9, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced it has acquired Tissuemed, Ltd. (Leeds, England), a privately held company that is an industry leader in developing self-adhesive surgical sealant films.
The acquisition of Tissuemed, Ltd. expands BD’s global offerings for surgeons outside of the United States. Tissuemed’s lead product, Tissuepatch, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions. The technology’s thin, flexible and transparent composition that is ready to use out of the package makes it ideally suited for a range of surgical sealant applications.
Tissuepatch is already trusted among surgeons due to its design, which enables strong adhesive and minimal swelling. This foundation provides BD with an opportunity to leverage its reach and clinical expertise to continue to innovate within the sealant technology category, which is expected to grow significantly over the next five to 10 years.
Terms of the transaction were not disclosed.